As per reported information, it has got revealed that 13 drug makers and many health organizations have united with the government to eliminate 10 tropical diseases by 2020. Some of the known drug companies and health organizations which have taken the pledge with the government are Astra and Glaxo and the Bill and Melinda Gates Foundation.

As per recent reports, it has been revealed that Johnson & Johnson on Friday announced that it is willingly summoning up a lot of its Aveeno Baby Calming Comfort Lotion, as an assessment carried out recently by the US Food and Drug Administration (FDA) has revealed that it was containing more sorts of bacteria than permissible as per its tagged specifications.

It has been recently revealed that Johnson & Johnson is going to pay a huge sum of $1 billion for the purpose of resolving civil investigation for the marketing of the drug Risperdal.

Irrespective of its benefit, the US drug advisers were of the view that Johnson and Johnson's Ortho Evra birth control patch should clearly indicate about risks it possess for women, like the potential danger of blood clots.

It has been revealed in a recent report that baby products manufacturing company Johnson and Johnson is on its drive to get rid of products that can be harmful for the little babies. This is being done after there was the presence of harmful chemicals in the baby shampoo by the company as well as a number of other products.

With the immediate-release version of the painkiller Nucynta having been way back approved in 2008, the extended-release version of the drug has now been approval by the US Food and Drug Administration (FDA).

The Food and Drug Administration has approved new Nucynta for the adults suffering from chronic pains, Johnson & Johnson notified Friday.

The painkiller is an extended-release edition, and can be taken twice a day by adults suffering low to high density of enduring pain.

A number of large, important drug companies have announced major cuts to the cost of the vaccines that they provide to people in the developing world. GlaxoSmithKline (GSK), Johnson & Johnson, Merck and Sanofi-Aventis have all said that they will cut prices for Gavi, an international vaccine alliance.

The results of phase III trial of drug abiraterone acetate have revealed that it extends on an average four months of life among men with prostate cancer. The drug is manufactured by Johnson & Johnson unit Centocor Ortho Biotech and is marketed as Zytiga.

Zytiga (abiraterone acetate), a drug manufactured by a major healthcare company Johnson & Johnson for treatment of metastatic prostate cancer among men, has been approved by the US Food and Drug Administration.